In 2017, Abbott Diagnostics released its latest generation of platforms for clinical chemistry, immunology, hematology, molecular diagnostics and “point of care” – Alinity. Some of the many benefits of the new family are: run more tests in less time in a smaller footprint, scalable systems with open connectivity, continuous access to solutions and supplies gives labs the ability to reload solutions without pausing or stopping the instruments and reduce human error.
The Alinity integrated system for clinical chemistry and immunoassay testing “Alinity ci” win “Best New Clinical Laboratory Instrumentation of 2017” award in 2018 Scientists’ Choice Awards for Clinical Lab Science Announced at AACC. With its flexibility, uniformity, operational productivity and confidence, Alinity represent harmonized systems across all key laboratory disciplines, which is important for the future of Clinical Laboratory.
